We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Conatus Pharmaceuticals's financial performance into perspective.
Apr 28, 2016
Apr 18, 2016
Conatus Late Breaker Oral Presentation at EASL Details Phase 2 Liver Cirrhosis Trial Three-month Data
Events & Presentations
May 5, 2016 at 8:00 AM ET